TL
TrueLocus
contact@truelocus.bio
Held-Out CRISPRi Benchmark (n = 72)

Resolving ambiguous non-coding screen hits.

Nearest-gene heuristics misassign ~46% of non-coding hits (measured on 72 held-out CRISPRi pairs). TrueLocus nominates causal distal targets using 3D contact priors and multi-promoter competition without requiring cell-type Hi-C.

Held-Out Empirical Benchmark

Evaluated on 72 experimental CRISPRi enhancer-gene pairs in K562 cells (Schraivogel et al. 2020, Nature Methods). Code was frozen and committed before evaluation.

Method Top-1 Accuracy Top-3 Target Recall Input Required
Nearest-TSS Baseline 54.2% (39/72) 73.6% (53/72) 1D Distance
TrueLocus Engine 69.4% (50/72) 84.7% (61/72) Sequence + CAGE (No Hi-C)
Broad ABC (Nasser 2021) 75.0% (54/72) 94.4% (68/72) Full K562 Hi-C + ChIP + ATAC

Paired exact test: TrueLocus vs Nearest Top-1 p=0.007 (McNemar exact, b=13, c=2). On the 33 non-nearest loci where enhancers skip the closest promoter, nearest-gene Top-3 recall collapses to 42%, while TrueLocus recovers 70%.

Per-locus results tables and full method description available on request; code review under NDA for qualified evaluators.

Services & Engagements

Free Pilot
Blind Screen Ranking
Send 3 to 5 ambiguous non-coding hits plus cell type. We return blind target predictions within 5 business days for validation against your internal experimental truth. Zero cost, no calls required.
Commercial
14-Day Locus De-Risking Audit
10 to 25 candidate screening hits audited per engagement. Deliverables include full candidate rankings, multi-promoter competition matrices, and vector-mapped boundary profiles. 14-day turnaround.

Inquiries & Contact

TrueLocus operates directly with functional genomics and target discovery screening teams. To test the engine on your hits or request full per-locus benchmark logs:

contact@truelocus.bio